UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia
A Phase II Open-label Study of ECT-001-expanded Cord Blood Transplantation in Patients With High-risk Acute Leukemia/Myelodysplasia
Sponsor: Ciusss de L'Est de l'Île de Montréal
This PHASE2 trial investigates Cord Blood Transplant and High Risk Hematologic Malignancy and is currently ongoing. Ciusss de L'Est de l'Île de Montréal leads this study, which shows 10 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Nov 2025 — Present [monthly]
Active Not Recruiting PHASE2
-
Sep 2025 — Nov 2025 [monthly]
Active Not Recruiting PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
Status: Unknown Status → Active Not Recruiting
▶ Show 5 earlier versions
-
Jan 2024 — Mar 2024 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Sep 2021 — Jan 2024 [monthly]
Recruiting PHASE2
-
Jan 2021 — Sep 2021 [monthly]
Recruiting PHASE2
-
Feb 2020 — Jan 2021 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
May 2019 — Feb 2020 [monthly]
Not Yet Recruiting PHASE2
First recorded
Apr 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ciusss de L'Est de l'Île de Montréal
- ExCellThera inc.
- Stem Cell Network
For direct contact, visit the study record on ClinicalTrials.gov .